PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.74%
Some net income increase while AVGO is negative at -67.96%. John Neff would see a short-term edge over the struggling competitor.
4.29%
D&A growth well above AVGO's 0.10%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-5300.00%
Negative yoy deferred tax while AVGO stands at 100.81%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-37.84%
Negative yoy SBC while AVGO is 6.42%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
94.19%
Slight usage while AVGO is negative at -8700.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
64.95%
AR growth well above AVGO's 5.42%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
55.17%
Some inventory rise while AVGO is negative at -66.07%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
750.00%
A yoy AP increase while AVGO is negative at -145.05%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
1.97%
Some yoy usage while AVGO is negative at -84.25%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
95.24%
Some yoy increase while AVGO is negative at -48.00%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
15.33%
Some CFO growth while AVGO is negative at -2.85%. John Neff would note a short-term liquidity lead over the competitor.
-48.59%
Negative yoy CapEx while AVGO is 36.51%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
48.59%
Less M&A spending yoy vs. AVGO's 99.85%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-155.48%
Both yoy lines negative, with AVGO at -4880.00%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
24.73%
Liquidation growth of 24.73% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-58.02%
Both yoy lines negative, with AVGO at -96.90%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-2082.72%
Both yoy lines negative, with AVGO at -12.26%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment similar to AVGO's 100.00%. Walter Schloss sees parallel liability management or similar free cash flow availability.
-46.08%
Negative yoy issuance while AVGO is 51.28%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-17.88%
Both yoy lines negative, with AVGO at -1459.37%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.